Target intelligence / Profile preview

Adhesion G protein-coupled receptor L1 (ADGRL1)

Target
ADGRL1
Molecular classification
G protein-coupled receptor, Adhesion G protein-coupled receptor, Receptor
01

Overview

Adhesion G protein-coupled receptor L1 (ADGRL1), also known as Latrophilin-1, is a member of the adhesion G protein-coupled receptor (aGPCR) family characterized by an extended extracellular region containing multiple protein domains, including lectin and olfactomedin domains, fused to a 7-transmembrane domain typical of GPCRs via a GAIN autoproteolysis domain[2][1]. ADGRL1 plays key roles in cell adhesion, synaptic development, and signal transduction in the nervous system[1][5][2]. It serves as a high-affinity receptor for the neurotoxin alpha-latrotoxin from black widow spider venom, which can induce massive neurotransmitter release[3][4]. Physiologically, ADGRL1 regulates synapse formation, neuronal signaling, and energy and glucose balance, and interacts with several ligands including teneurins, neurexins, and FLRT proteins[1][4][2]. Mutations in ADGRL1 are linked to neurodevelopmental and neuropsychiatric disorders, including intellectual disability, autism spectrum disorder, ADHD, epilepsy, and also contribute to obesity and cancer risk[1][7][5][3]. ADGRL1 is considered a prototypical adhesive GPCR important for brain function; however, as of current knowledge, it is not directly targeted by any approved pharmacological agents.

Other names
Latrophilin-1LPHN1CIRL1CIRL-1LEC2KIAA0821Calcium-independent alpha-latrotoxin receptor 1Lectomedin-2DEDBANP
02

Mechanism of action

Alpha-latrotoxin binds and activates ADGRL1, inducing massive exocytosis of neurotransmitters[3][4]. Endogenous peptide agonists activate G-protein signaling downstream[5]. General GPCR mechanism: Activation leads to intracellular G-protein signal transduction cascade[5][4].

03

Biological functions

Cell adhesionSignal transductionSynaptic developmentRegulation of exocytosisRegulation of neurotransmitter releaseEnergy and glucose metabolism
04

Disease associations

Neurodevelopmental disorderNeuropsychiatric disorderAttention-deficit/hyperactivity disorderAutism spectrum disorderEpilepsyCancerObesityBehavioral abnormalities
05

Safety considerations

No direct safety concerns from drug targeting, as no therapeutic antagonists/agonists are in use as of the available literature. However, mutations in ADGRL1 cause neurological and metabolic disorders, indicating that manipulation could potentially risk similar effects[1][7].
06

Interacting drugs

Alpha-latrotoxin (binds as a toxin/agonist)
07

Biomarkers

Mutations in ADGRL1 may serve as biomarkers for neurodevelopmental disorders or obesity risk, as seen in rare variant association with respective diseases[1][7].

Beyond the preview

Go deeper on Adhesion G protein-coupled receptor L1 (ADGRL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adhesion G protein-coupled receptor L1 (ADGRL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call